tenofovir alafenamide

The drug is intended for the treatment of adults and children (from 12 years of age with a body weight of at least 40 kg) infected with human immunodeficiency virus type 1 (HIV-1), in combination with other antiviral agents.

Form: tablets, film-coated

ATC: J05AR

Manufacturer: Maylan Laboratories Limited

It is used to treat chronic hepatitis B in adults and adolescents aged 12 years and older (provided that body weight is at least 35 kg).

Form: tablets, film-coated

ATC: J05AF13

Manufacturer: Nacto Pharma Limited

The drug is intended for the treatment of chronic hepatitis B in adults and children aged 6 years and older (with a body weight of at least 25 kg).

Form: tablets, film-coated

ATC: J05AF13

Manufacturer: Hetero Labs Limited

The drug is used for the treatment of adults and adolescents (from 12 years of age weighing at least 35 kg) infected with HIV-1, in combination with other antiretroviral agents. It is also indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection through sexual contact in men at risk.

Form: tablets, film-coated

ATC: J05AR17

Manufacturer: Anorra Pharma Private Limited

The drug is used for the treatment of HIV-1 infection in adults and adolescents (from 12 years of age weighing at least 35 kg) as part of combination therapy. It is also indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 sexual transmission in men at risk.

Form: tablets, film-coated

ATC: J05AR17

Manufacturer: Macleods Pharmaceuticals Limited

The drug is intended for the treatment of chronic hepatitis B in adults and adolescents (aged 12 years and older weighing at least 35 kg).

Form: tablets, film-coated

ATC: J05AF13

Manufacturer: Maylan Laboratories Limited